FCTA Launches Free Injectable HIV Prevention Drug in Abuja, Begins Pilot Rollout

The Federal Capital Territory is taking a major step in the fight against HIV with the introduction of a new long-acting prevention drug, offering residents a more convenient alternative to daily medication. Health authorities have confirmed that over 4,000 vials of the injectable treatment, known as LenPrEP, have been received and will be made available free of charge to eligible individuals.

The initiative was officially launched at Asokoro District Hospital in Abuja, where the Mandate Secretary for Health Services and Environment Secretariat, Adedolapo Fasawe, described the innovation as a significant breakthrough in HIV prevention. According to her, the introduction of LenPrEP represents a shift toward more flexible and user-friendly strategies, especially for people who find it difficult to maintain daily pill routines.

Unlike traditional oral preventive treatments, the new injection is administered just twice a year, making it a discreet and convenient option for those at higher risk of HIV exposure. Fasawe emphasized that while the injectable does not replace existing methods such as oral PrEP, condom use, and behavioral interventions, it strengthens the overall prevention framework.

The rollout is part of a broader effort by the Federal Capital Territory Administration to reduce new HIV infections and improve public health outcomes. With an HIV prevalence rate of about 1.4 percent in the FCT and over 60,000 people currently on treatment, authorities say prevention remains a critical priority.

As one of the selected pilot regions, Abuja will initially focus on individuals at higher risk, including discordant couples and those with occupational or lifestyle exposure. The phased implementation is expected to provide valuable insights into the effectiveness and adoption of the new drug before a nationwide expansion.

The program aligns with global targets set by UNAIDS, particularly the 95-95-95 goals aimed at ending the HIV epidemic. Officials believe that innovations like LenPrEP could accelerate progress toward achieving these benchmarks.

Beyond medication, FCT health authorities are also emphasizing a holistic approach to HIV care, incorporating nutritional support, mental health services, and social assistance for affected individuals. Fasawe stressed that addressing HIV requires more than just treatment—it involves supporting the overall well-being of patients.

The injectable will be available at selected healthcare facilities across Abuja, including major hospitals and primary healthcare centers, as well as through partner organizations. Residents have been encouraged to take advantage of the free service while avoiding stigma and ensuring the medication is not misused or sold illegally.

The rollout follows a broader national effort, with Nigeria recently receiving thousands of doses of Lenacapavir as part of a Global Fund-supported program. Several states, including the FCT, have been chosen for the pilot phase, which will help shape the future of HIV prevention in the country.

With this initiative, Abuja is positioning itself at the forefront of innovative healthcare solutions, raising hopes that the introduction of long-acting HIV prevention could significantly reduce new infections and move the country closer to an HIV-free future.